Caveolin-1 and Kidney Cancer Survival
Author Information
Author(s): Campbell L, Gumbleton M, Griffiths D F R
Primary Institution: Welsh School of Pharmacy, Cardiff University
Hypothesis
Does caveolin-1 expression serve as a prognostic marker for disease-free survival in renal cell carcinoma?
Conclusion
Caveolin-1 overexpression is associated with poor disease-free survival in patients with renal cell carcinoma.
Supporting Evidence
- Caveolin-1 expression correlates with poor prognosis in various cancers.
- Higher caveolin-1 scores were associated with shorter disease-free survival.
- Caveolin-1 overexpression may indicate a role in tumor progression.
Takeaway
This study found that higher levels of a protein called caveolin-1 in kidney tumors can mean patients are more likely to have their cancer come back after treatment.
Methodology
The study examined caveolin-1 expression in 114 renal cell carcinoma samples using immunohistochemistry and analyzed its impact on disease-free survival.
Potential Biases
Potential bias in patient selection and follow-up due to the retrospective nature of the study.
Limitations
The study is based on a small sample size from a single hospital, which may limit the generalizability of the findings.
Participant Demographics
Median age of participants was 63.6 years, with 76 men and 38 women.
Statistical Information
P-Value
0.0017
Confidence Interval
95% CI 5.76–7.46 for score 1; 4.53–6.30 for score 2; 1.87–4.44 for score 3
Statistical Significance
p=0.0017
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website